Breast Cancer Research Foundation

Springer Nature and the Breast Cancer Research Foundation Announce the Rising Scholars: Breast Cancer Program for Early Career Researchers

Retrieved on: 
Tuesday, March 26, 2024
General Health, Oncology, Training, Consumer, Other Education, Continuing, Education, Publishing, Science, Women, Communications, Health, Other Science, Breast cancer, Breast Cancer Research Foundation, University, Master, Disease, Partnership, Breast, Nature Portfolio, Research, Mortality, Nature, Cancer, BCRF, Woman, Workforce, Springer Nature, Disaster recovery, DEI, Writing, Management

Springer Nature and the Breast Cancer Research Foundation (BCRF) today announced the Rising Scholars: Breast Cancer program, a partnership between Nature Portfolio and BCRF which provides Early Career Researchers (ECRs) in the field of cancer with additional resources for professional development and career preparedness.

Key Points: 
  • Springer Nature and the Breast Cancer Research Foundation (BCRF) today announced the Rising Scholars: Breast Cancer program, a partnership between Nature Portfolio and BCRF which provides Early Career Researchers (ECRs) in the field of cancer with additional resources for professional development and career preparedness.
  • The Rising Scholars: Breast Cancer program is the result of over a decade of partnership between Springer Nature and BCRF.
  • BCRF has been a phenomenal and consistent partner for Springer Nature and was the first nonprofit to work with Springer Nature in adopting our data research solutions.
  • The new Rising Scholars: Breast Cancer program will provide concrete qualitative and quantitative data as to the impact of such endeavors going forward.

CertaPro Painters® Jake Kiser Awarded Franchisee of the Year by International Franchise Association

Retrieved on: 
Tuesday, February 27, 2024
BCSC, American Dream, BCRF, International Franchise Association, Breast cancer, Breast Cancer Research Foundation, Coffee, Breast, Reynolds cancer charities, Breast Cancer Awareness Month, Workforce, Film industry

PHOENIX, Feb. 27, 2024 /PRNewswire/ -- Jake Kiser, owner of CertaPro Painters of Athens, GA, has been named 2023 Franchisee of the Year by the International Franchise Association (IFA). Kiser was nominated by CertaPro Painters® and was honored at the 64th IFA Annual Convention in Phoenix for being an outstanding franchise establishment owner-operator. Nominated by their parent company, individuals are selected for their involvement in their communities, embodying the entrepreneurial spirit, fostering a strong and healthy culture with their workforce, and assisting their fellow franchisees when called upon. 

Key Points: 
  • Owner of CertaPro Painters of Athens, GA recognized for excellence in franchising
    PHOENIX, Feb. 27, 2024 /PRNewswire/ -- Jake Kiser, owner of CertaPro Painters of Athens, GA, has been named 2023 Franchisee of the Year by the International Franchise Association (IFA).
  • Kiser was nominated by CertaPro Painters® and was honored at the 64th IFA Annual Convention in Phoenix for being an outstanding franchise establishment owner-operator.
  • The IFA recognized CertaPro Painters® Jake Kiser with its highest honor awarded to individual franchisees.
  • "I am beyond proud of Jake Kiser for this amazing accomplishment," said Michael Stone, President and Chief Executive Officer of CertaPro Painters.

Community Foundation of Broward Adds Five New Board Members and Selects 2024 Board Officers

Retrieved on: 
Friday, February 23, 2024
CFO, Responsibility, Marketing, Certified Public Accountant, Senior, LGBTQ, Florida Power & Light, Community engagement, Water, Sale, Public sector, Chairperson, Executive Committee, Breast cancer, Breast Cancer Research Foundation, FPL, Spirit Airlines, Community foundation, Community, Communication, Management

FORT LAUDERDALE, Fla., Feb. 23, 2024 /PRNewswire/ -- The Community Foundation of Broward added five local leaders and selected officers for its 2024 Board of Directors. 

Key Points: 
  • FORT LAUDERDALE, Fla., Feb. 23, 2024 /PRNewswire/ -- The Community Foundation of Broward added five local leaders and selected officers for its 2024 Board of Directors.
  • New members of the Community Foundation Board of Directors include Ted Christie, Ramona Fowler, Alice Jackson, Brian Poulin and John Templeton.
  • The Community Foundation Board of Directors also has elected a full slate of officers.
  • For more information about Community Foundation of Broward, please email Kirk Englehardt, Vice President of Marketing and Communications at the Community Foundation ( [email protected] ) or call 954-761-9503.

Atossa Therapeutics Issues Letter to Shareholders

Retrieved on: 
Tuesday, January 9, 2024
Woman, Weill Cornell Medicine, Research, Breast cancer screening, Share repurchase, Exemestane, University, Neoadjuvant therapy, Prognosis, Cancer, Breast, Risk, Breast Cancer Research Foundation, Cell death, University of California, Mastectomy, Ductal carcinoma, Diagnosis, Nature Portfolio, Growth, Silicon, Quantum Leap, Therapy, Neoplasm, BCRF, Seminal vesicles, Breast cancer, Disease, Patient, Lymph, Apoptosis, Radiation, Letter, Recurrence, TNBC, Phenotype, DCIS, PKC, Partnership, Mayo Clinic, Plasma, Triple-negative breast cancer, AKT, Springer Nature, FDA, Biomarker, PCR, Phosphorylation, Medical imaging

SEATTLE, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announces the issuance of the following Letter to Shareholders from Steven Quay, M.D., Ph.D., the Company’s President and Chief Executive Officer:

Key Points: 
  • SEATTLE, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announces the issuance of the following Letter to Shareholders from Steven Quay, M.D., Ph.D., the Company’s President and Chief Executive Officer:
    2023 marked another year of significant progress for Atossa.
  • If you would like to learn more about the study, please visit www.atossatherapeutics.com to view a short video interview I conducted with Dr.
  • Adding to the issue is the fact that there are currently no approved treatments to reduce breast density.
  • On behalf of the board of directors, management, and employees of Atossa Therapeutics, we thank you for your investment and continued support of our Company.

CancerIQ Adds Dr. Jeffrey Weitzel, MD as Strategic Advisor

Retrieved on: 
Thursday, December 21, 2023
Natera, Partnership, Risk, Division, Research, Breast Cancer Research Foundation, Cancer Moonshot, City, NCCN, MD, Society, Panel, Education, Cancer, Genetics, Genomics, University, Breast cancer, Genetic testing, Patient, Diagnosis, American School, FACP, Pharmaceutical industry

CHICAGO, Dec. 21, 2023 /PRNewswire-PRWeb/ -- CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, announced today that Jeffrey Weitzel, MD, cofounder of the City of Hope Clinical Cancer Genomics Community of Practice, was named an official strategic advisor to the company. In this role, Dr. Weitzel's deep, cross-sector expertise will help inform research and product development and enrich CancerIQ's longstanding commitment to mainstreaming cancer genetics as part of routine care.

Key Points: 
  • CHICAGO, Dec. 21, 2023 /PRNewswire-PRWeb/ -- CancerIQ, the platform powering early cancer detection and prevention across broad patient populations, announced today that Jeffrey Weitzel, MD, cofounder of the City of Hope Clinical Cancer Genomics Community of Practice, was named an official strategic advisor to the company.
  • "As a strategic advisor to CancerIQ, I look forward to driving continued innovation in this space."
  • As a strategic advisor, Dr. Weitzel will work with CancerIQ to advance translational research in the delivery of cancer genetics and genomics.
  • "As a strategic advisor to CancerIQ, I look forward to driving continued innovation in this space."

A unique approach to cancer treatment: Piazza and his pharmacy team bring a new approach to cancer research at Auburn University

Retrieved on: 
Friday, December 1, 2023
NSAID, Medicine, Apoptosis, Lung, Pancreatic cancer, Nonsteroidal anti-inflammatory drug, Research, Hope, Breast cancer, Colorectal cancer, Tissue, Breast Cancer Research Foundation, RAS, Headache, Patient, Multimedia, UAB, MCI, FDA, Arthritis, Collaboration, Familial adenomatous polyposis, Auburn University, Polyp, Sulindac, Biomedical Research, Drug discovery, University, Cancer, Financial toxicity, HCOP, Cell division, Harrison College, Breast, Bangladesh Technical Education Board, Cell, Southern Research, Pharmaceutical industry, Nursing, Mobile phone, Pharmacy, Auburn

Piazza joined the Harrison College of Pharmacy (HCOP) in 2021 as the W.W. Walker Professor and head of the Department of Drug Discovery and Development.

Key Points: 
  • Piazza joined the Harrison College of Pharmacy (HCOP) in 2021 as the W.W. Walker Professor and head of the Department of Drug Discovery and Development.
  • Along with his administrative responsibilities, Piazza continues his groundbreaking research as director of the newly created Cancer Research Center at HCOP.
  • Piazza is optimistic that their lead compound, ADT-1004, is an attractive drug candidate inching closer and closer to clinical trials.
  • Piazza is excited about what can be accomplished on The Plains to be a beacon of hope in the battle to fight cancer.

TIME AND ALLY FINANCIAL HONOR ALABAMA DEALER

Retrieved on: 
Friday, October 27, 2023
National Automobile Dealers Association, Faculty, The Donoho School, Homelessness, Heart, Food, Breast Cancer Research Foundation, TIME, Hunter King (Home and Away), Hope, Family, Ally, North East Autism Society, Organization, University, Cystic Fibrosis Foundation, Multimedia, Coastal Alabama Community College, Wallace State Community College, Kennesaw State University, Risk, Cystic fibrosis, Organic, NADA, Rotary Club of SoHo Hong Kong, Turkey, Culture, Woman, Breast cancer, American Dream, Automotive industry, Security (finance), Car dealership, Management, Auction, Nursing, Ironworks, Nissan

New York, Oct. 27, 2023 /PRNewswire/ -- The nomination of Dale Benton, president of Benton Nissan of Hoover in Hoover, Alabama, for the 2024 TIME Dealer of the Year award was announced today by TIME.

Key Points: 
  • The TIME Dealer of the Year award is one of the automobile industry's most prestigious and highly coveted honors.
  • Benton attended Jefferson Davis Community College (now Coastal Alabama Community College) in Brewton, Alabama, and Kennesaw State College in Kennesaw, Georgia.
  • Doug Timmerman, president of dealer financial services, Ally, said, "Auto dealers nominated for the TIME Dealer of the Year award have demonstrated an unwavering commitment to not only the industry but to their respective communities through volunteerism, sponsorships, and supporting charitable causes, no matter the market climate.
  • Benton was nominated for the TIME Dealer of the Year award by Thomas R. Dart, president of the Automobile Dealers Association of Alabama.

Uniform Advantage Donates another $20,000 to the Breast Cancer Research Foundation

Retrieved on: 
Friday, October 13, 2023
Diagnosis, Uniform Advantage and AACN Nursing Scholarship, Partnership, UA, Hope, Breast cancer, Culture, Social responsibility, Breast Cancer Research Foundation, Disease, Human, Cancer, Estate (law), BCRF, Metastasis, Woman, Breast, Research, Pharmaceutical industry, Birth control

FORT LAUDERDALE, Fla., Oct. 13, 2023 /PRNewswire-PRWeb/ -- Uniform Advantage (UA), a multi-channel retailer of medical uniforms for medical and hospitality industries, is proud to continue its partnership with the Breast Cancer Research Foundation® (BCRF) with another $20,000 donation.

Key Points: 
  • Breast cancer is the most commonly diagnosed cancer among women worldwide, and BCRF is at the forefront of every major breakthrough in breast cancer prevention, diagnosis, treatment, survivorship, and metastasis.
  • Uniform Advantage's contribution directly contributes to BCRF's mission to prevent and cure breast cancer by advancing the world's most promising research.
  • Uniform Advantage CEO, Susan Masimore, expressed the company's commitment to the cause, saying, "We are deeply honored to stand beside the Breast Cancer Research Foundation in their tireless efforts to make a difference in the lives of those affected by breast cancer.
  • The Breast Cancer Research Foundation extends its heartfelt gratitude to Uniform Advantage for its unwavering commitment to the cause.

AutoNation Shifts Drive Pink Campaign Into High Gear to Drive Out Cancer

Retrieved on: 
Thursday, October 12, 2023
Health, NYSE, Memorial Regional Hospital (Florida), Phoenix Children's Hospital, AutoNation, American Cancer Society, Death, Research, Hard Rock Stadium, Breast cancer, NHS foundation trust, Organization, Dolphin, Breast Cancer Research Foundation, Mortality, DRV, Customer, Prostate, Holy Cross Hospital, Hospital, Wipe Out Kids' Cancer, Cancer, BCRF, Prostate cancer, H. Lee Moffitt Cancer Center & Research Institute, Breast, Patient, Cleveland Clinic, Birth control, Pharmaceutical industry

FORT LAUDERDALE, Fla., Oct. 12, 2023 /PRNewswire/ -- As part of an annual tradition, AutoNation, Inc. (NYSE: AN) gathered thousands of Associates coast to coast for Drive Pink (DRV PNK) Across America Day on October 11th.

Key Points: 
  • Associates in AutoNation stores from coast to coast joined in to delivering thousands more bags to local cancer facilities in their communities.
  • AutoNation Associates, Customers and communities have helped DRV PNK raise and donate over $35 million to cancer charities since 2013.
  • Nationally, AutoNation directs its support to BCRF, the American Cancer Society, the National Pediatric Cancer Foundation, and Zero: The End of Prostate Cancer.
  • AutoNation continues to offer its iconic DRV PNK license plate frames to drivers free of charge at all AutoNation stores, to drive awareness.

LAGOS INVITES CUSTOMERS TO "SHOP PINK, SAVE LIVES" IN SUPPORT OF THE BREAST CANCER RESEARCH FOUNDATION

Retrieved on: 
Friday, September 29, 2023
Caviar, Diamond, Partnership, Woman, Research, Breast, Sale, BCRF, Estate (law), Creative, Breast Cancer Research Foundation, Breast cancer, Metastasis, Heredity, Jewellery

NEW YORK, Sept. 29, 2023 /PRNewswire/ -- LAGOS, the fine jewelry brand known for its signature Caviar beaded designs, elevates its partnership with the Breast Cancer Research Foundation (BCRF) for 2023, donating 100 percent of sales from a special diamond style, to help the organization end breast cancer.

Key Points: 
  • The LAGOS Pink Ceramic and Diamond Caviar Ring features textured sterling silver Caviar beading and smooth, pink ceramic that surrounds sparkling diamonds.
  • From October 1 – December 31, 2023, LAGOS will donate 100 percent of each ring sale to BCRF, with more than $60,000 donated since 2020.
  • Globally, breast cancer causes the greatest number of cancer-related deaths among women, and incidence rates are on the rise.
  • "Breast cancer has impacted so many of those close to me, to our employees, and to our customers.